Table 5A.
DXA and pQCT outcomes used in intention to treat analyses for the FES-T and CONV groups at baseline, 4 months and 12 months. The values are shown as mean change (standard deviation). N=17 in each group with last observation carried forward in cases of missing data
| FES-T | P-value* | CONV | P-value* | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 4 months | 12 months | Baseline | 4 months | 12 months | |||
| 17 | 17 | 17 | 17 | 17 | 17 | |||
| aBMD | ||||||||
| Left Total Hip (g/cm2) | 0.89 (0.20) |
0.88 (0.20) |
0.88 (0.20) |
0.42 | 0.86 (0.24) |
0.87 (0.23) |
0.88 (0.23) |
0.02 |
| Left Distal Femur (g/cm2) | 0.89 (0.16) |
0.87 (0.15) |
0.87 (0.14) |
0.12 | 0.81 (0.18) |
0.80 (0.18) |
0.81 (0.17) |
0.62 |
| Left Proximal Tibia (g/cm2) | 0.71 (0.18) |
0.71 (0.15) |
0.69 (0.17) |
0.24 | 0.68 (0.19) |
0.66 (0.19) |
0.67 (0.19) |
0.27 |
| 17 | 17 | 17 | 17 | 17 | 17 | |||
| pQCT | ||||||||
| 38% TbvBMD (mg/cm3) | 87.69 (17.11) |
91.13 (17.45) |
89.06 (20.43) |
0.09 | 88.45 (27.17) |
90.82 (21.45) |
93.09 (31.62) |
0.03 |
| 38% CTh (mm) | 3.88 (0.89) |
3.88 (0.96) |
3.75 (0.78) |
0.04 | 4.27 (1.19) |
4.18 (1.08) |
3.91 (0.94) |
0.15 |
| 38% Cortical Density | 1089.31 (37.48) |
1087.62 (34.42) |
1082.0 (36.85) |
0.10 | 1106.73 (34.04) |
1102.36 (37.78) |
1100.00 (26.22) |
0.04 |
| PMI (mm4) | 58558.03 (18002.27) |
58557.63 (18377.84) |
59377.30 (20364.38) |
0.02 | 44640.33 (16882.90) |
43396.61 (16863.27) |
43774.16 (17166.62) |
0.08 |
| SSI | 2866.34 (778.20) |
2902.53 (789.56) |
2925.79 (829.38) |
0.05 | 2429.00 (739.62) |
2389.76 (743.69) |
2359.34 (716.79) |
0.17 |
| 4% Tbv BMD (mg/cm3) | 201.99 (35.65) |
189.43 (53.96) |
200.51 (35.89) |
0.05 | 171.40 (52.47) |
166.54 (52.47) |
169.35 (51.00) |
0.18 |
Least Significant Change for DXA is 2% for the Distal Femur and 3% for the Proximal Tibia.
*Within group P-value